Skip to content
value.today

Clear Catheter Systems, Inc

🇺🇸 Bend, Oregon, USAHealth CareFounded 2006
Total raised
$48 M
9 rounds on record
Latest round
$2 M
Jul 2025
First round on record
Sep 2010
Today
Private
No later event on record

Funding rounds

9 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Clear Catheter Systems, Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$2 MNo. 9$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 9, Jul 2025

Investors in this round

2 investors had bought by the notice of Aug 5, 2025: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Promissory Note and Preferred Stock Warrants and the underlying preferred stock issuable upon conversion and exercise thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hannah Beathard · Executive Officer
  • Paul Molloy · Executive Officer, Director
  • Alexander Suh · Director
  • Christopher Martin · Director
  • Edward M. Boyle · Director
  • Ned Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hannah Beathard, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 5, 2025. Read the notice at the SEC.

debt, optionsSEC
Jun 2024$2 MNo. 8$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 8, Jun 2024

Investors in this round

2 investors had bought by the notice of Jun 28, 2024: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible Promissory Note and Preferred Stock Warrants and the underlying preferred stock issuable upon conversion and exercise thereof.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hannah Beathard · Executive Officer
  • Paul Molloy · Executive Officer, Director
  • Alexander Suh · Director
  • Christopher Martin · Director
  • Edward M. Boyle · Director
  • Ned Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Hannah Beathard, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 28, 2024. Read the notice at the SEC.

debt, optionsSEC
Aug 2020$8 MNo. 7$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 7, Aug 2020

Investors in this round

5 investors had bought by the notice of Aug 25, 2020: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Molloy · Executive Officer, Director
  • Alexander M. Suh · Director
  • Christopher M. Martin · Director
  • Edward M. Boyle · Director
  • Ned M. Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Molloy, President and CEO. Source: SEC Form D, newest notice filed Aug 25, 2020. Read the notice at the SEC.

equity, optionsSEC
May 2019$8 MNo. 6$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 6, May 2019

Investors in this round

8 investors had bought by the notice of May 15, 2019: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $12 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Molloy · Executive Officer, Director
  • Alexander M. Suh · Director
  • Edward M. Boyle · Director
  • Ned M. Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Molloy, President and CEO. Source: SEC Form D, newest notice filed May 15, 2019. Read the notice at the SEC.

equitySEC
Feb 2018$13 MNo. 5$10 to $50 million

Clear Catheter Systems, Inc: Raise no. 5, Feb 2018

Investors in this round

6 investors had bought by the notice of Aug 13, 2018: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Molloy · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Molloy, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 13, 2018. Read the notice at the SEC.

equitySEC
Jul 2015$6 MNo. 4$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 4, Jul 2015

Investors in this round

2 investors had bought by the notice of Aug 10, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $9 M offered; $3 M still to sell
Smallest investment taken
$2,750,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Paul Molloy · Executive Officer, Director
  • Alexander D. suh · Director
  • Andrew D. Firlik · Director
  • Edward M. Boyle, Jr. · Director
  • Ned D. Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Molloy, President & CEO. Source: SEC Form D, newest notice filed Aug 10, 2015. Read the notice at the SEC.

equitySEC
Nov 2013$4 MNo. 3$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 3, Nov 2013

Investors in this round

5 investors had bought by the notice of Feb 4, 2014: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$150,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Molloy M. Paul · Executive Officer, Director
  • Alexander M. Suh · Director
  • Andrew M. Firlik · Director
  • Edward M. Boyle, Jr. · Director
  • Ned M. Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Molloy, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Feb 4, 2014. Read the notice at the SEC.

equitySEC
Dec 2011$5 MNo. 2$2 to $10 million

Clear Catheter Systems, Inc: Raise no. 2, Dec 2011

Investors in this round

4 investors had bought by the notice of Jan 5, 2012: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$750,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edward M. Boyle, Jr. · Executive Officer, Director
  • Alex M. Suh · Director
  • Andrew M. Firlik · Director
  • Ned M. Scheetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Edward M. Boyle, Jr., Chief Executive Offficer. Source: SEC Form D, newest notice filed Jan 5, 2012. Read the notice at the SEC.

equitySEC
Sep 2010$1 MNo. 1Under $2 million

Clear Catheter Systems, Inc: Raise no. 1, Sep 2010

Investors in this round

15 investors had bought by the notice of Oct 5, 2010: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$9,999
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Edward M. Boyle, Jr. · Executive Officer, Director
  • Andrew M. Firlik · Director
  • George M. Trutza · Director
  • James M. Fee · Director
  • Sam M. Kiderman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Edward M. Boyle, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 5, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Clear Catheter Systems, Inc chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • Revenue range over time, as stated in its notices: revenue of up to $1 million in 2010; revenue of up to $1 million in 2012; revenue between $1 million and $5 million in 2014; no revenue in 2015.

    SEC Form D (revenue range) · Aug 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Clear Catheter Systems, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 9 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Clear Catheter Systems, Inc
NameRoleNamed in
Hannah BeathardExecutive officerAug 2025
Paul MolloyExecutive officerAug 2025
Molloy M. PaulExecutive officerFeb 2014
Edward M. Boyle, Jr.Executive officerJan 2012
Alexander SuhDirectorAug 2025
Christopher MartinDirectorAug 2025
Edward M. BoyleDirectorAug 2025
Ned ScheetzDirectorAug 2025
Paul MolloyDirectorAug 2025
Alexander M. SuhDirectorAug 2020
Christopher M. MartinDirectorAug 2020
Ned M. ScheetzDirectorAug 2020
Alexander D. suhDirectorAug 2015
Andrew D. FirlikDirectorAug 2015
Edward M. Boyle, Jr.DirectorAug 2015
Ned D. ScheetzDirectorAug 2015
Andrew M. FirlikDirectorFeb 2014
Molloy M. PaulDirectorFeb 2014
Alex M. SuhDirectorJan 2012
George M. TrutzaDirectorOct 2010
James M. FeeDirectorOct 2010
Sam M. KidermanDirectorOct 2010